Neuberger Berman Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-970,841
| Closed | -$96.4M | – | 1646 |
|
|
2019
Q3 | $96.4M | Sell |
970,841
-188,390
| -16% | -$17.9M | 0.12% | 257 |
|
|
2019
Q2 | $107M | Buy |
1,159,231
+45,949
| +4% | +$4.36M | 0.13% | 235 |
|
|
2019
Q1 | $105M | Buy |
1,113,282
+842,127
| +311% | +$73.6M | 0.13% | 232 |
|
|
2018
Q4 | $17.4M | Sell |
271,155
-136,978
| -34% | -$10.1M | 0.02% | 595 |
|
|
2018
Q3 | $36.5M | Buy |
408,133
+10,316
| +3% | +$912K | 0.04% | 481 |
|
|
2018
Q2 | $31.6M | Sell |
397,817
-220,158
| -36% | -$18.3M | 0.03% | 522 |
|
|
2018
Q1 | $55.1M | Sell |
617,975
-502,273
| -45% | -$48.2M | 0.06% | 387 |
|
|
2017
Q4 | $117M | Sell |
1,120,248
-639,777
| -36% | -$72.2M | 0.13% | 228 |
|
|
2017
Q3 | $257M | Sell |
1,760,025
-67,748
| -4% | -$9.23M | 0.32% | 71 |
|
|
2017
Q2 | $237M | Sell |
1,827,773
-17,064
| -0.9% | -$2.09M | 0.3% | 77 |
|
|
2017
Q1 | $230M | Buy |
1,844,837
+71,729
| +4% | +$8.58M | 0.3% | 85 |
|
|
2016
Q4 | $205M | Sell |
1,773,108
-527,405
| -23% | -$58.7M | 0.28% | 96 |
|
|
2016
Q3 | $240M | Sell |
2,300,513
-147,022
| -6% | -$15.9M | 0.33% | 72 |
|
|
2016
Q2 | $241M | Sell |
2,447,535
-121,619
| -5% | -$12.6M | 0.33% | 71 |
|
|
2016
Q1 | $257M | Buy |
2,569,154
+1,925,968
| +299% | +$198M | 0.35% | 68 |
|
|
2015
Q4 | $77M | Sell |
643,186
-80,685
| -11% | -$9.33M | 0.1% | 278 |
|
|
2015
Q3 | $78.3M | Buy |
723,871
+246,849
| +52% | +$30.6M | 0.1% | 279 |
|
|
2015
Q2 | $55.2M | Sell |
477,022
-74,178
| -13% | -$8.48M | 0.06% | 395 |
|
|
2015
Q1 | $63.5M | Sell |
551,200
-418,582
| -43% | -$50M | 0.07% | 373 |
|
|
2014
Q4 | $108M | Sell |
969,782
-252,240
| -21% | -$26.6M | 0.11% | 254 |
|
|
2014
Q3 | $116M | Buy |
1,222,022
+11,572
| +1% | +$1.04M | 0.12% | 239 |
|
|
2014
Q2 | $104M | Sell |
1,210,450
-49,596
| -4% | -$3.77M | 0.1% | 288 |
|
|
2014
Q1 | $88M | Buy |
1,260,046
+208,228
| +20% | +$16.5M | 0.09% | 326 |
|
|
2013
Q4 | $88.9M | Buy |
1,051,818
+671,170
| +176% | +$53.1M | 0.09% | 328 |
|
|
2013
Q3 | $29.3M | Buy |
380,648
+147,296
| +63% | +$10.3M | 0.03% | 530 |
|
|
2013
Q2 | $13.6M | Buy |
+233,352
| New | +$14M | 0.02% | 693 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Neuberger Berman Group's CELG Position: Q4 2019 in Review
Neuberger Berman Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 970,841 shares — an estimated $96.4M sold.
Neuberger Berman Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $257M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Neuberger Berman Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Neuberger Berman Group sold 970,841 Celgene Corp shares in Q4 2019, an estimated $96.4M.
- Neuberger Berman Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Neuberger Berman Group's Celgene Corp position peaked at $257M in Q1 2016.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Neuberger Berman Group's 13F filing for Q4 2019, filed 12 Feb 2020.